26286-51-1

Usage

Uses

Used in Pharmaceutical Industry:
2-methyl-1-(2-nitrophenyl)imidazole is used as a building block for the synthesis of pharmaceuticals due to its potential biological and medicinal properties. Its unique structure allows it to be a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, 2-methyl-1-(2-nitrophenyl)imidazole is utilized as a building block for the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Material Science:
2-methyl-1-(2-nitrophenyl)imidazole is also investigated for its potential use in the development of new materials, thanks to its chemical properties and structural characteristics.
Used in Coordination Chemistry:
As a potential ligand, 2-methyl-1-(2-nitrophenyl)imidazole is explored in coordination chemistry for its ability to form complexes with metal ions, which can lead to advances in various chemical and material applications.
Used in Antimicrobial and Anti-Fungal Applications:
2-methyl-1-(2-nitrophenyl)imidazole has been studied for its antimicrobial and antifungal activities, making it a candidate for use in applications that require the inhibition of microbial growth, such as in medical or environmental settings.

Upstream product

• 693-98-1 2-methylimidazole 
• 1493-27-2 ortho-nitrofluorobenzene 
• 823-96-1 Trimethylboroxine 
• 1043391-18-9 2-bromo-1-(2-nitrophenyl)-1H-imidazole 

Downstream Products

• 26286-55-5 1-(2-amino)phenyl-2-methylimidazole 

Relevant academic research and scientific papers

Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and?Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors

The transcription nuclear factor NF-κB plays a pivotal role in chronic and acute inflammatory diseases. Among the several and diverse strategies for inhibiting NF-κB, one of the most effective approach considered by the pharmaceutical industry seems to be

In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives

Imidazoquinoxaline and pyrazoloquinoxaline derivatives, analogues of imiquimod, were synthesized, and their in vitro cytotoxic and pharmacodynamic activities were evaluated. In vitro cytotoxicity studies were assessed against melanoma (A375, M4Be, RPMI-75

Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogues

A series of novel imidazoquinoxalinones and their aza analogues were prepared by the cyclization of o-amino(1H-imidazol-1-yl)aryls and heteroaryls with carbonyldiimidazole. The compounds were screened for inhibition of Type I and Type IV phosphodiesterase